CNS Response Inc (OTCQB:CNSO)

Data as of Jan 30
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Services
Services to the Health Industry

Company Description

CNS Response, Inc. operates as a clinical decision support company with a patented commercial neurometric platform to predict drug response for the treatment of brain disorders, including depression, anxiety, bipolar disorder and post-traumatic stress disorder. The company offers an improvement over traditional methods for evaluating pharmacotherapy options in patients suffering from non-psychotic behavioral disorders. CNS Response was founded by Leonard J. Brandt and Brain McDonald on March 20, 1987 and is headquartered in Aliso Viejo, CA.

Contact Information

CNS Response, Inc.
85th Enterprise
Aliso Viejo California 92656-2614
P:(949) 420-4400
Investor Relations:



Individual stakeholders52.18%
Mutual fund holders3.92%
Other institutional2.47%

Top Executives

George C. CarpenterPresident & Chief Executive Officer
Paul BuckChief Financial Officer & Secretary
Brian MacDonaldChief Technology Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.